Meningitis WisdomCard™

FDA: Pharmacy's other drugs may be causing illness - Yahoo! News

news.yahoo.com — “From Yahoo! News: Two more drugs from a specialty pharmacy linked to a meningitis outbreak are now being investigated, U.S. health officials said, as they urged doctors to contact patients who got any kind of injection from the company.” View full resource at news.yahoo.com

Most Recently Shared on October 23, 2012 at 10:42 am By:

In Oct. of 2009, Sue became a Certified Natural Health Professional, and in 2011 became Certified as a Digestive Health Specialist through the Loomis Institute of Enzyme Nutrition, and is also a member of the American Holistic Nurses Association. Sue has a private practice in Green Bay, WI., but has the priviledge of having and serving clients in areas of Nova Scotia, Boston, Minnesota, West Virginia, and the Fox Valley area of WI. She maintains her current WI Nursing Licensure. We welcome you to contact us about cancer-fighting supplements used in Sue's treatment." /> Suzan Macco RN Nurse and Active Health Library

Bacteria may be talking to each other with a contact-dependent language

news-medical.net — “What if bacteria could talk to each other? What if they had a sense of touch? A new study by researchers at UC Santa Barbara suggests both, and theorizes that such cells may, in fact, need to communicate in order to perform certain functions. The findings appear today in the journal Genes & Development.” View full resource at news-medical.net

Most Recently Shared on March 2, 2012 at 3:33 pm By:

News-Medical.Net Health News

Meningitis News: Bacteria may be talking to each other with a contact-dependent language: What if bacteria could... http://t.co/yGG2tBNJ

1 year ago...

Retweet

Favorite

Phase I study of Shigella dysenteriae bioconjugate vaccine meets primary, secondary endpoints

news-medical.net — “GlycoVaxyn AG, a leader in the development of innovative vaccines, announced today that the Phase I study of its Shigella dysenteriae bioconjugate vaccine has been completed and met the primary and secondary endpoints: demonstration of safety and immunogenicity.” View full resource at news-medical.net